Clinical Trials Logo

Typhoid and Paratyphoid Fevers clinical trials

View clinical trials related to Typhoid and Paratyphoid Fevers.

Filter by:
  • None
  • Page 1

NCT ID: NCT00269295 Completed - Clinical trials for Typhoid and Paratyphoid Fevers

TY800 Dose Escalation (Typhoid)

Start date: February 2006
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this research study is to determine whether a new vaccine for typhoid fever is safe and effective. This study will also look at what effects (good and bad) this new vaccine, Ty800, has on the volunteers. The study will determine the highest dose of Ty800 that can be given without causing severe side effects. About 54 healthy males and females, ages 18-45 inclusive, in the Cincinnati metropolitan area will be enrolled in this study. They will be in the study for approximately 7 months, which includes a one month screening period, study product administration on Day 0, a 10-day hospital stay, an outpatient period on Days 9-28 with 4 follow-up visits, and safety follow-up phone calls at 2 and 6 months after hospital discharge. Researchers hope that this trial will help produce a vaccine that combines a high level of durable protective immunity with simplicity of administration and minimal reaction to the vaccine.